Roche plans to launch drugs and slash development costs
Swiss pharma group is a high spender on R&D but has had misses in Alzheimer’s and cancer
Info Econômico – Seu Portal de Notícias Econômicas
Fonte Roche plans to launch drugs and slash development costs